Disclaimer | LogIn     
1546-2080 Online :: 1546-203X Print
Global Developments in Nano-Enabled Drug Delivery Markets
Volume 2, Issue 2

Michael Moradi, Venture Development Associates

The drug delivery industry is at an inflection point in its celebrated history, and a period of rapid change looms on the horizon. As drug delivery companies increasingly focus efforts upstream, they will collaborate with the drug discovery industry to an even greater degree. At the same time, industrial nanotechnology is bearing fruit for investors and presents new opportunities for the drug delivery industry. Nano-enabled drug delivery systems are rapidly emerging to address pharmaceutical industry challenges with regard to solubility, cost-reduction, marketing, higher disease targeting and lifecycle extension. A combination of factors within the drug delivery and nanotechnology industries are producing a greater synergy between nanotechnology and advanced drug delivery systems, including early success of nanotechnology commercial applications, intense patent competition, successful governmental nanotechnology initiatives around the globe and general excitement about nanotechnology and its application. While the industry undoubtedly faces challenges, there are silver linings and the prospect of immense opportunity.

Full Text (PDF)
Home   :   Aims & Scope    :   Editorial Board    :   Subscriptions   :   Partnerships  :   Contact Us
Nanotechnology Law & Business Copyright 2005